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resolved by week 4. No clinically significant abnormalities on
neurological exam, ECG, cognitive testing (HVLT-R) and postural
vital signs were noted.
Conclusions: A single infusion of RN624 reduced pain in sub-
jects with OA of the knee. The peak effect on pain reduction
was observed at approximately 4 weeks post infusion and sus-
tained for 8 weeks thereafter. The reduction in pain was more
pronounced in walking pain. RN624 improved the subject’s func-
tional status including reduced pain while walking, improved
functional activities, and less stiffness (WOMAC subscales). A
trend of dose response in pain reduction was observed among
the lower dose cohorts 3, 10, 30, 100 μg/kg RN624 and the
maximum effect was observed in the 100 μg/kg RN624 group.
The abnormal pain-related adverse events observed appear to
be dose related. The onset and resolution occurred during the
first 4 weeks before the peak effect. The timing of the adverse
events coincided with the reduced efficacy seen transiently in
higher dose groups.
RN624, with well-defined pain relief and tolerability profiles, has
the potential to be useful in the management of chronic pain due
to OA.
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Purpose: The 110kd fibronectin-fragment (FN-f) has been found
to stimulate chondrocyte MMP-13 expression through the activa-
tion of an α5β1 integrin cell-signaling pathway. We have recently
shown that reactive oxygen species (ROS) are required sec-
ondary messengers in the activation of key components of this
pathway including PYK-2, MAP kinases, c-Jun, and NFkB. Ox-
idation of specific cysteine residues, resulting in the formation
of protein sulfenic acids, is a key step in several redox-sensitive
signaling pathways but has not been investigated in integrin path-
ways or in chondrocyte signaling. The objective of the present
study was to utilize a proteomics approach to determine key
redox proteins regulated by sulfenic acid formation in α5β1 sig-
naling that results in chondrocyte MMP-13 expression.
Methods: Human articular chondrocytes, isolated from nor-
mal ankle cartilage, were stimulated in serum-free media with
25μg/ml of the 110kD FN-f in the presence and absence of dime-
done, a reagent which reacts specifically with protein sulfenic
acids. The requirement for sulfenic acid formation in FN-f me-
diated integrin signaling was determined by pre-treating cells
with dimedone (0, 1, 5, 10, 20mM) for 30 mins followed by FN-f
stimulation. Activation of PYK2, MAP kinases, Akt, c-Jun and
NF-κB was measured by immunoblotting cell lysates, prepared
5-45 mins after FN-f stimulation, with phosphorylation-specific
antibodies while MMP-13 production was measured in the con-
ditioned media from cultures treated overnight. Cell survival was
analyzed by staining with calcein and ethidium bromide. Detec-
tion of sulfenic acid-containing proteins formed in response to
FN-f stimulation was performed by adding 5mM of a biotinylated
dimedone analogue (DCP-biotin) to the cell lysis buffer after
FN-f stimulation (rather than pre-treating with dimedone). Un-
stimulated controls were also treated with DCP-biotin in a similar
fashion. Labeled proteins were then pulled down with streptavidin
beads and analyzed on 1-D and 2-D gels.
Results: Pre-treatment with dimedone significantly inhibited FN-
f-stimulated MMP-13 production in a dose dependent manner
with maximal inhibition at 20mM with no reduction in cell sur-
vival at this dose. The inhibition of MMP-13 production was
associated with inhibition of phosphorylation of PYK2 and the
MAP kinases ERK, JNK, and p38 as well as c-Jun and the p65
subunit of NFκB. Of these, the JNK-2 isoform appeared to be
most sensitive with inhibition noted at 5mM dimedone while the
others required 10-20mM. Unlike the others, phosphorylation of
Akt, which is required for anabolic rather than catabolic signal-
ing, was increased with 20mM dimedone pre-treatment. When
DCP-biotin was added after FN-f stimulation, at least 5 proteins
containing sulfenic acid were noted that were uniquely labeled
in FN-f stimulated samples compared to controls. One of these
was identified as JNK-2. Sulfenic acid formation in JNK-2 was
confirmed in chondrocytes transfected with a Flag-tagged JNK-2
expression construct.
Conclusions: These results are the first to show that generation
of protein sulfenic acids is required for the FN-f stimulated inte-
grin signaling which mediates MMP-13 production. JNK-2 was
identified as a key redox-sensitive signaling intermediate but oth-
ers upstream of PYK2 are also likely involved. The specific Cys
residue modified to Cys sulfenic acid in JNK-2 is currently being
identified. Defining the redox sensitive secondary messengers
that regulate MMP-13 expression should aid in the develop-
ment of novel therapeutic targets capable of reducing cartilage
destruction in arthritis.
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Purpose: Degradation of articular cartilage characterised by pro-
teolysis of aggrecan and the type II collagen network is a central
feature of osteoarthritis (OA). Significant collagenolysis by matrix
metalloproteinases (MMPs) may signify the point of irreversible
cartilage damage. Numerous catabolic agents upregulate chon-
drocyte synthesis of MMPs, but the mechanism whereby these
enzymes are activated is unclear. Increased levels of Activated
Protein C (APC), an anticoagulant serine protease, are found in
OA. APC is generated through the action of thrombin bound to
thrombomodulin (TM) cleaving protein C (PC) bound to a its cell
surface receptor (EPCR). APC is known to activate MMP-2 but its
potential role in cartilage degradation has not been investigated.
Methods: Ovine articular cartilage was cultured ± 10ng/ml IL-1,
100ng/ml TNF-alpha or 10-6M retinoic acid (RA) ± 2-20 μg/ml
APC ± a broad spectrum MMP inhibitor (marimastat, 300nM) for
4 days. In some experiments cartilage was cultured with APC for
24-96 hours, washed and then incubated with IL-1 or RA. The
release of sulfated glycosaminoglycan (GAG) and hydroxyproline
(HyPro) was compared using ANOVA and Student-Newman-
Keuls post-hoc analysis. MMP-2 and -9 activity in media was
examined by gelatin zymography, and MMP-13 activity measured
with a fluorogenic substrate. In replicate cultures, RNA was
extracted from cartilage and expression of ADAMTS-1, -4 &-5;
MMP-1, -2, -3, -9, -13 &-14; TIMPs 1-4; and PC, EPCR and
TM were evaluated using RT-PCR. PC was immunolocalised
in osteochondral sections of developing human joints and in
cartilage from normal and OA human cartilage.
Results: IL-1, TNF and RA significantly increased cartilage
GAG release (40-60% of total) but did not induce collagen
breakdown over 4 days of culture. APC alone (2-20μg/ml)
had no effect on GAG or collagen release, however, it sig-
nificantly augmented GAG loss from IL-1 and TNF (>80% of
total) but not RA stimulated cultures. In IL-1 and TNF but not
RA stimulated cultures, APC caused substantial collagen (4-
15% of total) loss over 4 days. MMP inhibition abrogated the
APC-augmented GAG and collagen release. Pre-culture with
APC prior to washing and subsequent cytokine stimulation, in-
